LINCO-SPECTIN 100, 222/444.7 MG/G POWDER FOR USE IN DRINKING WATER FOR PIGS AND CHICKENS

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Αγόρασέ το τώρα

Κατεβάστε Αρχείο Π.Χ.Π. (SPC)
12-06-2017

Δραστική ουσία:

SPECTINOMYCIN (AS SPECTINOMYCIN SULPHATE PH.EUR.), LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Διαθέσιμο από:

Zoetis Ireland Limited

Φαρμακολογική κατηγορία (ATC):

QJ01FF52

INN (Διεθνής Όνομα):

SPECTINOMYCIN (AS SPECTINOMYCIN SULPHATE PH.EUR.), LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Δοσολογία:

222/444.7

Φαρμακοτεχνική μορφή:

Powder for Oral Solution

Τρόπος διάθεσης:

POM: Prescription Only Medicine as defined in relevant national legislation

Θεραπευτική ομάδα:

Fowl - Chicken, Porcine

Θεραπευτική περιοχή:

lincomycin, combinations

Θεραπευτικές ενδείξεις:

Antibacterial

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2015-02-06

Αρχείο Π.Χ.Π.

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Linco-Spectin 100, 222/444.7 mg/g Powder for use in drinking water for
pigs and chickens
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCES:
Lincomycin (as lincomycin hydrochloride)
222 mg
Spectinomycin (as spectinomycin sulphate)
444.7 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
White pale powder for use in drinking water.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs and chickens.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs
For the treatment and metaphylaxis of porcine proliferative
enteropathy (ileitis) caused by_ Lawsonia intracellularis_,
and associated enteric pathogens (_Escherichia coli_) susceptible to
lincomycin and spectinomycin.
The presence of the disease in the group must be established before
the product is used.
Chickens
For the treatment and metaphylaxis of chronic respiratory disease
(CRD) caused by_ Mycoplasma gallisepticum_ and
_Escherichia coli_ susceptible to lincomycin and spectinomycin, and
associated with a low mortality rate.
The presence of the disease in the flock must be established before
the product is used.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or any
of the excipients.
Do not use in case of hepatic dysfunction.
Do not allow rabbits, rodents (e.g. chinchillas, hamsters, guinea
pigs), horses or ruminants to access to water or feeds
containing lincomycin. Ingestion by these species may result in severe
gastrointestinal effects.
Do not use in laying hens.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν